Eur Rev Med Pharmacol Sci 2014; 18 (18): 2687-2692

Association between bevacizumab-related chemotherapy regimens and serum vascular endothelial growth factor-A165b level in patients with metastatic colorectal cancer

L. Xu, C. Chi, C. Wang, L.M. Zhang

Department of Oncology of the Affiliated Yantai Yuhuangding Hospital of Medical College Qingdao University, Yantai, China. liangmingzhang11@tom.com

The paper has been withdrawn

Free PDF Download

To cite this article

L. Xu, C. Chi, C. Wang, L.M. Zhang
Association between bevacizumab-related chemotherapy regimens and serum vascular endothelial growth factor-A165b level in patients with metastatic colorectal cancer

Eur Rev Med Pharmacol Sci
Year: 2014
Vol. 18 - N. 18
Pages: 2687-2692

Keywords Related articles:

  1. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients
  2. Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients
  3. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats
  4. Kidney vasculogenesis and angiogenesis: role of Vascular Endothelial Growth Factor
  5. The role of IVS14+1 G > A genotype detection in the dihydropyrimidine dehydrogenase gene and pharmacokinetic monitoring of 5-fluorouracil in the individualized adjustment of 5-fluorouracil for patients with local advanced and metastatic colorectal cancer: a preliminary report